|
Volumn 12, Issue 3, 1998, Pages 5-9
|
Looking down the drug pipeline.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2',3' DIDEOXYADENOSINE;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
CHEMOKINE RECEPTOR CCR5;
CHEMOKINE RECEPTOR CXCR4;
CHLOROBENZENE;
DRUG DERIVATIVE;
FP 21399;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
METHYLPHOSPHONIC ACID PINACOLYL ESTER;
NAPHTHALENE DERIVATIVE;
NEW DRUG;
PROTEINASE INHIBITOR;
PYRIMIDINONE DERIVATIVE;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
SOMAN;
ANIMAL;
ANTIBIOTIC RESISTANCE;
ARTICLE;
BIOAVAILABILITY;
CLINICAL TRIAL;
CODON;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
METABOLISM;
ANIMALS;
ANTI-HIV AGENTS;
BIOLOGICAL AVAILABILITY;
CHLOROBENZENES;
CLINICAL TRIALS;
CODON;
DIDEOXYADENOSINE;
DRUG RESISTANCE, MICROBIAL;
DRUGS, INVESTIGATIONAL;
GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR;
HIV INFECTIONS;
HIV PROTEASE INHIBITORS;
HUMANS;
NAPHTHALENES;
PYRIMIDINONES;
RECEPTORS, CCR5;
RECEPTORS, CXCR4;
REVERSE TRANSCRIPTASE INHIBITORS;
SOMAN;
|
EID: 0032012509
PISSN: 10771824
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (3)
|
References (0)
|